1. Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis
   Yoon Khei Ho et al, 2024, Journal of Translational Medicine CrossRef
2. Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review
   Reshma Murali et al, 2023, Medical Oncology CrossRef
3. Harnessing type I interferon-mediated immunity to target malignant brain tumors
   Juhee Lim et al, 2023, Frontiers in Immunology CrossRef
4. The Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in Glioma: A Narrative Review
   Marjan Hesari et al, 2023, Journal of Interferon & Cytokine Research CrossRef
5. Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells
   Dakota W. Goad et al, 2023, Journal of Virology CrossRef
6. Combining PD-1/PD-L1 blockade with type I interferon in cancer therapy
   Ali Razaghi et al, 2023, Frontiers in Immunology CrossRef
7. The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression
   Nalini Srinivas et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
8. Protumorigenic Interferon-Stimulated Genes in Cancer: A Comprehensive Review
   Danial Qasim Butt et al, 2024, Cureus CrossRef
9. Preclinical evaluation of IAP0971, a novel immunocytokine that binds specifically to PD1 and fuses IL15/IL15Rα complex
   Jihong Chen et al, 2023, Antibody Therapeutics CrossRef
10. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7
    Wujun Chen et al, 2024, Cardiovascular Diabetology CrossRef
11. Effects of Interferon-α on Depressive-Like Behavior and Brain Neurochemistry in Rats Housed in Standard and Overcrowding Conditions
    N. A. Loginova et al, 2023, Journal of Evolutionary Biochemistry and Physiology CrossRef